Julia Tobacyk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Julia Tobacyk has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Lisa K. Brents
Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, 4301 W. Markham Street, Mail Slot 611, Little Rock, AR 72205, United States of America
3 shared publications - Michael D. Berquist
Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, 4301 W. Markham Street, Mail Slot 611, Little Rock, AR 72205, United States of America
2 shared publications B.J. Parks
Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, 4301 W. Markham Street, Mail Slot 611, Little Rock, AR 72205, United States of America
1 shared publicationBrian J Parks
Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, 4301 W. Markham Street, Mail Slot 611, Little Rock, AR 72205, USA
1 shared publicationBrian Parks
Univ of Arkansas for Medical Sciences
1 shared publication- Grishma Kc
Donald W. Reynolds Department of Geriatrics and Institute on Aging, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
1 shared publication
Latest Publications
- 28 March 2024
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 239, 173756
Limited bedding and nesting increases ethanol drinking in female rats
- 28 March 2024
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 239, 173756
Limited bedding and nesting increases ethanol drinking in female rats
- Open Access
- 18 May 2023
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 385 (S3) , 215
Effects of a two-hit model of early life adversity on oral ethanol self-administration and adrenergic receptor expression in adolescent rats
ID 24021 Poster Board 215 Alcohol (EtOH) use significantly contributes to the three leading causes of death among adolescents: unintentional injuries, suicide, and homicide. Adolescents consume more EtOH per drinking occurrence than adults. Early life adversities (ELA), including prenatal opioid exposure (POE) and postnatal adverse experiences, increase the risk of problematic EtOH use among adolescents. POE is any exposure to opioids during gestation and postnatal adverse experiences include abuse, neglect, or household dysfunction, such as parental substance use disorder. Because they often co-occur and are risk factors for early EtOH use, we investigated the relationship between POE, postnatal adversity, and adolescent EtOH. We also aimed to determine how α-adrenoceptor activity is affected by these ELAs to in turn affect adolescent EtOH intake. To model POE, pregnant rats received 15 mg/kg/day morphine or vehicle via subcutaneous minipumps from gestational day 9 to birth. To model postnatal adversity, we used limited bedding and nesting (LBN) procedures in which dams and litters were restricted to 20% of normal bedding and nesting materials from postnatal day (PD) 3 to 11. LBN increases maternal stress and decreases maternal care quality. Starting on PD 31 or 33, rats were given access to bottles containing either a 20% EtOH (v/v) solution or water under an intermittent-access, two-bottle choice procedures for 24-hour sessions, three days per week for four weeks (12 sessions). Rats received either yohimbine (1 mg/kg; ip) or vehicle 30-min prior to each EtOH access session to determine if pharmacologically-induced sympathomimetic activity enhances the acquisition of EtOH in adolescent rats and to assess for altered α2-adrenoceptor activity in rats that experienced POE and/or LBN. Cortices and brainstems from littermates without EtOH exposure were harvested on either PD 30 or PD 70 and used in radioligand receptor binding assays to quantify α1- and α2-adrenoceptor density. We hypothesized that adolescents with a history of combined POE and LBN (“two-hit” group) will consume more EtOH, have higher brain densities of α1-adrenoceptor, and have lower brain densities of α2-adrenoceptor than adolescents with either condition alone. In general, female rats drank more EtOH than male rats, and EtOH consumption was more affected by treatment condition in females than males. For example, female rats, more so than male rats, in the two-hit treatment group drank more EtOH after administration of yohimbine. Also, in the two-hit group, there was a decrease in EtOH consumption compared to the LBN and control groups within each sex. In our adrenoceptor density study, there was no difference in α1-adrenoceptor expression between males and females and across treatment groups. However, in the female cortex, there was high variability and a main effect of sex in α2-adrenoceptor expression with male expression being greater. Together, these results indicate a complex interaction between ELA, sex, and α-adrenoceptor activity that may support a stress inoculation hypothesis. Support/Funding Information: NIDA 5T32DA022981 ABI/ACRI Grant Award
- 18 May 2023
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 385 (S3) , 215
Open AccessEffects of a two-hit model of early life adversity on oral ethanol self-administration and adrenergic receptor expression in adolescent rats
ID 24021 Poster Board 215 Alcohol (EtOH) use significantly contributes to the three leading causes of death among adolescents: unintentional injuries, suicide, and homicide. Adolescents consume more EtOH per drinking occurrence than adults. Early life adversities (ELA), including prenatal opioid exposure (POE) and postnatal adverse experiences, increase the risk of problematic EtOH use among adolescents. POE is any exposure to opioids during gestation and postnatal adverse experiences include abuse, neglect, or household dysfunction, such as parental substance use disorder. Because they often co-occur and are risk factors for early EtOH use, we investigated the relationship between POE, postnatal adversity, and adolescent EtOH. We also aimed to determine how α-adrenoceptor activity is affected by these ELAs to in turn affect adolescent EtOH intake. To model POE, pregnant rats received 15 mg/kg/day morphine or vehicle via subcutaneous minipumps from gestational day 9 to birth. To model postnatal adversity, we used limited bedding and nesting (LBN) procedures in which dams and litters were restricted to 20% of normal bedding and nesting materials from postnatal day (PD) 3 to 11. LBN increases maternal stress and decreases maternal care quality. Starting on PD 31 or 33, rats were given access to bottles containing either a 20% EtOH (v/v) solution or water under an intermittent-access, two-bottle choice procedures for 24-hour sessions, three days per week for four weeks (12 sessions). Rats received either yohimbine (1 mg/kg; ip) or vehicle 30-min prior to each EtOH access session to determine if pharmacologically-induced sympathomimetic activity enhances the acquisition of EtOH in adolescent rats and to assess for altered α2-adrenoceptor activity in rats that experienced POE and/or LBN. Cortices and brainstems from littermates without EtOH exposure were harvested on either PD 30 or PD 70 and used in radioligand receptor binding assays to quantify α1- and α2-adrenoceptor density. We hypothesized that adolescents with a history of combined POE and LBN (“two-hit” group) will consume more EtOH, have higher brain densities of α1-adrenoceptor, and have lower brain densities of α2-adrenoceptor than adolescents with either condition alone. In general, female rats drank more EtOH than male rats, and EtOH consumption was more affected by treatment condition in females than males. For example, female rats, more so than male rats, in the two-hit treatment group drank more EtOH after administration of yohimbine. Also, in the two-hit group, there was a decrease in EtOH consumption compared to the LBN and control groups within each sex. In our adrenoceptor density study, there was no difference in α1-adrenoceptor expression between males and females and across treatment groups. However, in the female cortex, there was high variability and a main effect of sex in α2-adrenoceptor expression with male expression being greater. Together, these results indicate a complex interaction between ELA, sex, and α-adrenoceptor activity that may support a stress inoculation hypothesis. Support/Funding Information: NIDA 5T32DA022981 ABI/ACRI Grant Award
- 8 August 2022
- Published by Elsevier in International Journal of Drug Policy
- Vol. 108, 103817
Qualitative content analysis of public responses to an FDA inquiry on the impact of scheduling changes to kratom
- 8 August 2022
- Published by Elsevier in International Journal of Drug Policy
- Vol. 108, 103817
Qualitative content analysis of public responses to an FDA inquiry on the impact of scheduling changes to kratom
- Open Access
- 11 August 2021
- Published by MDPI AG in Antioxidants
- Vol. 10 (8) , 1272
Overexpression of MnSOD Protects against Cold Storage-Induced Mitochondrial Injury but Not against OMA1-Dependent OPA1 Proteolytic Processing in Rat Renal Proximal Tubular Cells
Kidneys from deceased donors undergo cold storage (CS) preservation before transplantation. Although CS is a clinical necessity for extending organ quality preservation, CS causes mitochondrial and renal injury. Specifically, many studies, including our own, have shown that the triggering event of CS-induced renal injury is mitochondrial reactive oxygen species (mROS). Here, we explored the role of OMA1-depedent OPA1 proteolytic processing in rat kidney proximal tubular epithelial (NRK) cells in an in vitro model of renal CS (18 h), followed by rewarming (6 h) (CS + RW). The involvement of mROS was evaluated by stably overexpressing manganese superoxide dismutase (MnSOD), an essential mitochondrial antioxidant enzyme, in NRK cells. Western blots detected rapid OPA1 proteolytic processing and a decrease in ATP-dependent cell viability in NRK cells subjected to CS + RW compared to control cells. Small interfering RNA (siRNA) knockdown of OMA1 reduced proteolytic processing of OPA1, suggesting that OMA1 is responsible for OPA1 proteolytic processing during CS + RW-induced renal injury. Overexpression of MnSOD during CS + RW reduced cell death, mitochondrial respiratory dysfunction, and ATP-dependent cell viability, but it did not prevent OMA1-dependent OPA1 processing. These data show for the first time that OMA1 is responsible for proteolytically cleaving OPA1 in a redox-independent manner during renal cell CS.
- 11 August 2021
- Published by MDPI AG in Antioxidants
- Vol. 10 (8) , 1272
Open AccessOverexpression of MnSOD Protects against Cold Storage-Induced Mitochondrial Injury but Not against OMA1-Dependent OPA1 Proteolytic Processing in Rat Renal Proximal Tubular Cells
Kidneys from deceased donors undergo cold storage (CS) preservation before transplantation. Although CS is a clinical necessity for extending organ quality preservation, CS causes mitochondrial and renal injury. Specifically, many studies, including our own, have shown that the triggering event of CS-induced renal injury is mitochondrial reactive oxygen species (mROS). Here, we explored the role of OMA1-depedent OPA1 proteolytic processing in rat kidney proximal tubular epithelial (NRK) cells in an in vitro model of renal CS (18 h), followed by rewarming (6 h) (CS + RW). The involvement of mROS was evaluated by stably overexpressing manganese superoxide dismutase (MnSOD), an essential mitochondrial antioxidant enzyme, in NRK cells. Western blots detected rapid OPA1 proteolytic processing and a decrease in ATP-dependent cell viability in NRK cells subjected to CS + RW compared to control cells. Small interfering RNA (siRNA) knockdown of OMA1 reduced proteolytic processing of OPA1, suggesting that OMA1 is responsible for OPA1 proteolytic processing during CS + RW-induced renal injury. Overexpression of MnSOD during CS + RW reduced cell death, mitochondrial respiratory dysfunction, and ATP-dependent cell viability, but it did not prevent OMA1-dependent OPA1 processing. These data show for the first time that OMA1 is responsible for proteolytically cleaving OPA1 in a redox-independent manner during renal cell CS.